Literature DB >> 19333044

Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: a clinical, prospective cohort study with one-year follow-up.

Mogens T Stender1, Jens B Frøkjaer, Torben B Larsen, Søren Lundbye-Christensen, Ole Thorlacius-Ussing.   

Abstract

PURPOSE: The study examined if preoperative plasma D-dimer level was associated with the postoperative cumulative incidence of deep venous thrombosis in patients with colorectal cancer admitted for intended curative surgery.
METHODS: In 176 consecutive patients with newly-diagnosed colorectal cancer and absence of preoperative deep venous thrombosis, we measured the preoperative plasma D-dimer levels and performed compression ultrasonography for deep venous thrombosis prior to surgery, as well as one week, one month, and one year after surgery.
RESULTS: The cumulative incidence of deep venous thrombosis up to one year after surgery was 20 percent (95 percent confidence interval, 12 to 31 percent) in the positive D-dimer group compared with 5 percent (95 percent confidence interval, 2 to 12 percent) in the negative D-dimer group. The adjusted hazard ratio of deep venous thrombosis in the positive vs. the negative D-dimer group was 6.53 (95 percent confidence interval, 1.58 to 27.0).
CONCLUSIONS: A positive preoperative D-dimer was associated with a higher cumulated incidence of postoperative deep venous thrombosis. D-dimer might be useful in identifying those colorectal cancer patients who fail to respond to standard prophylaxis for deep venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333044     DOI: 10.1007/DCR.0b013e318197e2b2

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

Review 1.  Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

Authors:  Minh Phan; Sonia John; Ana I Casanegra; Suman Rathbun; Aaron Mansfield; Julie A Stoner; Alfonso J Tafur
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 2.  Venous thrombosis and cancer: from mouse models to clinical trials.

Authors:  Y Hisada; J E Geddings; C Ay; N Mackman
Journal:  J Thromb Haemost       Date:  2015-06-26       Impact factor: 5.824

Review 3.  Cancer and coagulation.

Authors:  Alok A Khorana
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

4.  Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study.

Authors:  Ehsan Motavaf; Kåre Gotschalck Sunesen; Mogens Tornby Stender; Ole Thorlacius-Ussing
Journal:  Int J Colorectal Dis       Date:  2014-08-23       Impact factor: 2.571

Review 5.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

Review 6.  The role of thromboprophylaxis in cancer patients: emerging data.

Authors:  Laurel A Menapace; Alok A Khorana
Journal:  Curr Opin Hematol       Date:  2010-09       Impact factor: 3.284

7.  Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.

Authors:  Florian Moik; Florian Posch; Ella Grilz; Werner Scheithauer; Ingrid Pabinger; Gerald Prager; Cihan Ay
Journal:  Thromb Res       Date:  2020-01-07       Impact factor: 3.944

8.  Application of the Adaptive Validation Substudy Design to Colorectal Cancer Recurrence.

Authors:  Lindsay J Collin; Anders H Riis; Richard F MacLehose; Thomas P Ahern; Rune Erichsen; Ole Thorlacius-Ussing; Timothy L Lash
Journal:  Clin Epidemiol       Date:  2020-02-03       Impact factor: 4.790

Review 9.  Cancer-Associated Thrombosis: A New Light on an Old Story.

Authors:  Sidrah Shah; Afroditi Karathanasi; Antonios Revythis; Evangelia Ioannidou; Stergios Boussios
Journal:  Diseases       Date:  2021-05-04

Review 10.  D-Dimer elevation and adverse outcomes.

Authors:  Rim Halaby; Christopher J Popma; Ander Cohen; Gerald Chi; Marcelo Rodrigues Zacarkim; Gonzalo Romero; Samuel Z Goldhaber; Russell Hull; Adrian Hernandez; Robert Mentz; Robert Harrington; Gregory Lip; Frank Peacock; James Welker; Ignacio Martin-Loeches; Yazan Daaboul; Serge Korjian; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.